FIELD: medicine.
SUBSTANCE: invention relates to a compound of general formula (I), and pharmaceutically acceptable salts thereof where R1 represents a hydroxy C1-C6 alkyl group or hydroxy C3-C6 cycloalkyl group, each of which can be substituted with 1-3 substitutes selected from a subgroup of substitutes α, substitutes subgroup α is a group consisting of hydroxyl groups and carbamoyl group, R2 is a methyl group or ethyl group, R3 represents C1-C6 alkyl group or C3-C6 cycloalkyl group each of which can be substituted with 1-3 halogen atoms, and R4 is a halogen atom. Invention also relates to individual compounds; a pharmaceutical composition possessing hypoglycemic action and/or protective action on βcells or pancreas, containing as an active ingredient, compound, use of compounds for preparing pharmaceutical composition; a method of treating type 1 diabetes or diabetes type 2; and to a method for protection of β-cells or pancreas.
EFFECT: obtaining novel compounds of general formula (I), having hypoglycemic action and/or protective action on β-cells or pancreas.
35 cl, 56 ex
Title | Year | Author | Number |
---|---|---|---|
AMIDE DERIVATIVE | 2010 |
|
RU2536409C2 |
CONDENSED QUINOLINE DERIVATIVE AND USE THEREOF | 2005 |
|
RU2384571C2 |
COMPOUND CONTAINING OXADIAZOLE AND A PHARMACEUTICAL COMPOSITION CONTAINING IT | 2019 |
|
RU2789456C2 |
NOVEL CYCLIC HYDROCARBON COMPOUNDS FOR TREATMENT OF DISEASES | 2008 |
|
RU2524949C2 |
SULPHONAMIDE COMPOUND OR SALT THEREOF | 2017 |
|
RU2732572C2 |
[1,8]NAPHTHYRIDINE DERIVATIVES, USEFUL AS INHIBITORS OF HCV VIRUS REPLICATION | 2006 |
|
RU2467007C2 |
ANTITUMOR AGENT | 2018 |
|
RU2770824C2 |
DERIVATIVES OF HETEROARYLCARBAMOYLBENZENE | 2004 |
|
RU2330030C2 |
TRIAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITION COMPRISING THEREOF, USING TRIAZOLE COMPOUNDS AND METHOD FOR TREATMENT OF FUNGAL INFECTION | 2002 |
|
RU2276670C2 |
ARYL-SUBSTITUTED CARBOXAMIDE DERIVATIVES AS CALCIUM OR SODIUM CHANNEL BLOCKERS | 2010 |
|
RU2575168C2 |
Authors
Dates
2016-06-10—Published
2011-10-13—Filed